Bright Minds Biosciences is working with Firefly Neuroscience, an AI healthcare company, to provide a full analysis of the electroencephalogram data in Bright Minds' Phase 2 clinical trial evaluating ...
On Friday, Bright Minds Biosciences Inc (DRUG) stock saw a modest uptick, ending the day at $47.21 which represents a slight increase of $25.51 or 117.56% from the prior close of $21.7. The stock ...
Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the private ...